drugset / Trial / NCT00755872
Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate
RandomizedCrossoverOpen-label
Summary
This is a randomized, open-label, multi-center, 4-treatment, 4-period crossover study. Approximately 72 healthy, surgically sterile or postmenopausal subjects will be enrolled and have urine collected over 72 hours following administration of risedronate for all 4 treatment periods).
Timeline
- Start
- 2007-11
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | 35 mg | — |
Indications
No indication recorded.